ZA883599B - Mixed crystals of insulin and insulin derivatives,a process for the preparation of these mixed crystals,pharmaceutical agents containing these mixed crystals,and the use thereof for the treatment of diabetes mellitus - Google Patents

Mixed crystals of insulin and insulin derivatives,a process for the preparation of these mixed crystals,pharmaceutical agents containing these mixed crystals,and the use thereof for the treatment of diabetes mellitus

Info

Publication number
ZA883599B
ZA883599B ZA883599A ZA883599A ZA883599B ZA 883599 B ZA883599 B ZA 883599B ZA 883599 A ZA883599 A ZA 883599A ZA 883599 A ZA883599 A ZA 883599A ZA 883599 B ZA883599 B ZA 883599B
Authority
ZA
South Africa
Prior art keywords
mixed crystals
insulin
treatment
diabetes mellitus
preparation
Prior art date
Application number
ZA883599A
Other languages
English (en)
Inventor
Michale Doerschug
Doerschug Michale
Rainer Obermeier
Obermeier Rainer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA883599B publication Critical patent/ZA883599B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA883599A 1987-05-22 1988-05-20 Mixed crystals of insulin and insulin derivatives,a process for the preparation of these mixed crystals,pharmaceutical agents containing these mixed crystals,and the use thereof for the treatment of diabetes mellitus ZA883599B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873717370 DE3717370A1 (de) 1987-05-22 1987-05-22 Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus

Publications (1)

Publication Number Publication Date
ZA883599B true ZA883599B (en) 1989-01-25

Family

ID=6328227

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA883599A ZA883599B (en) 1987-05-22 1988-05-20 Mixed crystals of insulin and insulin derivatives,a process for the preparation of these mixed crystals,pharmaceutical agents containing these mixed crystals,and the use thereof for the treatment of diabetes mellitus

Country Status (20)

Country Link
US (1) US5028587A (fr)
EP (1) EP0291863B1 (fr)
JP (1) JPS63303930A (fr)
KR (1) KR880013572A (fr)
AT (1) ATE71842T1 (fr)
AU (1) AU601280B2 (fr)
CA (1) CA1335924C (fr)
DE (2) DE3717370A1 (fr)
DK (1) DK278088A (fr)
ES (1) ES2032896T3 (fr)
FI (1) FI93797C (fr)
GR (1) GR3004344T3 (fr)
HU (1) HU203840B (fr)
IE (1) IE60649B1 (fr)
IL (1) IL86452A (fr)
NO (1) NO175641C (fr)
NZ (1) NZ224715A (fr)
PH (1) PH25587A (fr)
PT (1) PT87523B (fr)
ZA (1) ZA883599B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
WO1992010284A2 (fr) 1990-12-07 1992-06-25 Cnc Development, Inc. Reacteur chimique catalytique
AU669110B2 (en) * 1991-05-24 1996-05-30 Amylin Pharmaceuticals, Inc. Amylin and possibly insulin containing composition for the treatment of anorexia and related states
DK72793D0 (da) * 1993-06-21 1993-06-21 Novo Nordisk As Nyt produkt
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
US5504188A (en) * 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US5547929A (en) * 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
US5597893A (en) * 1994-10-31 1997-01-28 Eli Lilly And Company Preparation of stable insulin analog crystals
US6004549A (en) * 1994-12-14 1999-12-21 Schering Corporation Crystalline protein controlled release compositions
CO4970787A1 (es) * 1997-12-23 2000-11-07 Lilly Co Eli Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
DE19903125B4 (de) * 1999-01-27 2006-01-05 Sanofi-Aventis Deutschland Gmbh Verfahren zur Trocknung von Kristallen von Insulin oder Insulinanaloga
CN1125081C (zh) * 1999-09-08 2003-10-22 中国科学院上海生物化学研究所 重组天然和新型人胰岛素及其制备方法
NZ526672A (en) * 2001-02-09 2006-10-27 Genentech Inc Process for forming crystalline human insulin-like growth factor-1
US7396936B1 (en) 2004-11-09 2008-07-08 Kemia, Inc. Modulators of calcitonin and amylin receptor activity
JP2010510988A (ja) * 2006-11-28 2010-04-08 マリナス ファーマシューティカルズ ナノ粒子製剤とその製造方法およびその利用
US9822158B2 (en) 2013-12-04 2017-11-21 Merck Sharp & Dohme Corp. Method for preparing crystalline insulin
EP3185887B1 (fr) 2014-08-26 2021-03-10 Merck Sharp & Dohme Corp. Procédé de préparation de compositions d'analogue d'insuline ou d'insuline cristallines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2538018A (en) * 1944-04-04 1951-01-16 Nordisk Insulinlab Crystalline product of insulin and alkaline protein and process of making it
EG12098A (en) * 1974-04-13 1980-12-31 Hoechst Ag New pharmaceutical insulin preparations having antidiabetic activity and process for their manufacture
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3333640A1 (de) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung

Also Published As

Publication number Publication date
ATE71842T1 (de) 1992-02-15
EP0291863A2 (fr) 1988-11-23
DE3867903D1 (de) 1992-03-05
DK278088A (da) 1988-11-23
IL86452A0 (en) 1988-11-15
HUT46546A (en) 1988-11-28
PH25587A (en) 1991-08-08
AU601280B2 (en) 1990-09-06
NO882207D0 (no) 1988-05-20
NO882207L (no) 1988-11-23
NO175641C (no) 1994-11-09
DE3717370A1 (de) 1988-12-01
IL86452A (en) 1993-02-21
JPS63303930A (ja) 1988-12-12
HU203840B (en) 1991-10-28
AU1648788A (en) 1988-11-24
ES2032896T3 (es) 1993-03-01
FI93797C (fi) 1995-06-12
NZ224715A (en) 1990-04-26
FI882354A (fi) 1988-11-23
EP0291863A3 (en) 1990-04-04
US5028587A (en) 1991-07-02
GR3004344T3 (fr) 1993-03-31
FI882354A0 (fi) 1988-05-19
IE60649B1 (en) 1994-08-10
PT87523A (pt) 1989-05-31
IE881522L (en) 1988-11-22
KR880013572A (ko) 1988-12-21
EP0291863B1 (fr) 1992-01-22
DK278088D0 (da) 1988-05-20
NO175641B (fr) 1994-08-01
FI93797B (fi) 1995-02-28
PT87523B (pt) 1992-09-30
CA1335924C (fr) 1995-06-13

Similar Documents

Publication Publication Date Title
AU601280B2 (en) Mixed crystals of insulin and insulin derivatives, a process for the preparation of these mixed crystals, pharmaceutical agents containing these mixed crystals, and the use thereof for the treatment of diabetes mellitus
ZA845620B (en) Novel insulin derivatives,processes for their preparation and their use,and pharmaceutical agents for the treatment of diabetes mellitus
IL82209A0 (en) Insulin preparation
ATE31625T1 (de) Pharmazeutisches mittel zur behandlung des diabetes mellitus.
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
YU101385A (en) Process for obtaining crystal calcium pseudomonate or its hydrate
HUT51138A (en) Process for production of medical composition against osteoporosis containing derivatives of imidasole /1,2-a/-piridasine or pirasine
GR861803B (en) Novel carbonic acid derivatives method for their preparation their use and medicine containing them
IL90551A0 (en) Stable,injectable,aqueous pharmaceutical compositions for the treatment of cardiac conditions
HU904201D0 (en) Process for producing peptides with haemoregulating effect and pharmaceutical preparatives containing these compounds
YU222189A (en) 2-azabicyclo (2.2.1) hept-5-en-2-ocetic acid, it's derivatives and familiar compounds, process for obtaining those compounds and use for obtaining n- phosphono-methylglycine
UA8036A1 (uk) Спосіб одержання похідних тіазолу або їх кислотно-аддітивних солей
HUT46904A (en) Process for production of derivatives of 1,3,5-tritian and medical compounds containing such substances
Veyssier et al. Concentrations of moxalactam in ventricular CSF during the treatment of a Klebsiella pneumoniae.
EG19461A (en) Process for preparing of s-substituted betathioacrylamides and their use as microbicide.
SU1840597A1 (ru) Способ получения бис-(хлороксимино)-ацетона
YU125289A (en) Process for preparing pharmaceutic compounds with delayed effect of healing substance, for oral use, which contains new inclusion complex of nicardipine, or it's hydrochloride with beta-cyclodextrine
HU9201315D0 (en) Process for the production of medical preparations containing 4-/n,n-dibenzyl-amino/-butyric acid or butyric amid as active agent, or their medically useful salts
HUT43833A (en) Process for production of derivatives of 3,4-dihydropirimidin and medical compounds containing thereof